NervGen Pharma Corp. operates as a clinical stage biotech company. It provides development of treatment that enables the nervous system to repair itself following damage, whether due to injury or disease. The company was founded by Harold Punnett and William Joseph Radvak on January 19, 2017 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of NervGen Pharma Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. NervGen Pharma Corp market cap is $178.06M.
What is the 52-week high for NervGen Pharma Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. NervGen Pharma Corp 52 week high is $5.10 as of September 26, 2025.
What is the 52-week low for NervGen Pharma Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. NervGen Pharma Corp 52 week low is $1.46 as of September 26, 2025.
What is NervGen Pharma Corp stock price today?
NervGen Pharma Corp stock price today is $2.37.
What was NervGen Pharma Corp stock price yesterday?
NervGen Pharma Corp stock price yesterday was $2.43.
What is the PE ratio of NervGen Pharma Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. NervGen Pharma Corp’s P/E ratio is -8.91.
What is the Price-to-Book ratio of NervGen Pharma Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. NervGen Pharma Corp P/B ratio is -262.9870.
What is the 50-day moving average of NervGen Pharma Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. NervGen Pharma Corp 50-day moving average is $2.50.
